Apollo Hospitals Enterprise Ltd - Stock Valuation and Financial Performance

BSE: 508869 | NSE: APOLLOHOSP | Hospital & Healthcare Services | Mid Cap

Apollo Hospital Ent. Share Price

7,000 17.60 0.25%
as on 31-Oct'24 16:01

DeciZen - make an informed investing decision on Apollo Hospital Ent.

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

Apollo Hospitals Enterprise stock performance -

mw4me loader
P/E Ratio (SA):
96.31
Market Cap:
1,00,946.9 Cr.
52-wk low:
4,789.2
52-wk high:
7,320

Is Apollo Hospitals Enterprise Ltd an attractive stock to invest in?

1. Is Apollo Hospitals Enterprise Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Apollo Hospitals Enterprise Ltd is a average quality company.

2. Is Apollo Hospitals Enterprise Ltd undervalued or overvalued?

The key valuation ratios of Apollo Hospitals Enterprise Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Apollo Hospitals Enterprise Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Apollo Hospitals Enterprise Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Apollo Hospital Ent.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Apollo Hospitals Enterprise Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 12.4%10.5%9.3%8.8%10.6%15.5%4.1%14%17.4%17.2%-
Value Creation
Index
-0.1-0.1-0.3-0.4-0.20.4-0.60.30.60.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4,5935,5886,3017,1838,3379,7944,6546,0986,5257,2747,522
Sales YoY Gr.-21.7%12.8%14%16.1%17.5%-52.5%31%7%11.5%-
Adj EPS 25.32620.617.122.124.3-1.140.276.170.372.9
YoY Gr.-2.6%-20.6%-17.1%28.8%10.4%-104.5%NA89.1%-7.6%-
BVPS (₹) 227.2238.3257.3265.5279286.5361.7424.9481.6536.2553.8
Adj Net
Profit
352361287238307339-15.65781,0931,0111,048
Cash Flow from Ops. 3896266325399071,0969151,2011,2251,191-
Debt/CF from Ops. 4.33.84.45.63.62.92.51.71.41.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.2%-2.7%16.1%11.5%
Adj EPS 12%26.1%NA-7.6%
BVPS10%14%14%11.4%
Share Price 20.1% 36.8% 17.3% 46%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
11.511.28.36.68.18.6-0.310.216.813.813.4
Op. Profit
Mgn %
14.913.412.311.612.314.515.423.32624.724.6
Net Profit
Mgn %
7.76.54.63.33.73.5-0.39.516.813.913.9
Debt to
Equity
0.50.70.80.80.80.80.40.30.30.3-
Working Cap
Days
13513113714113312225120523624185
Cash Conv.
Cycle
36303134333043101-454

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 16.05%

Sales growth is good in last 4 quarters at 12.58%

Return on Equity has declined versus last 3 years average to 13.40%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Apollo Hospitals Enterprise Ltd.

Standalone Consolidated
TTM EPS (₹) 72.9 72.1
TTM Sales (₹ Cr.) 7,522 19,727
BVPS (₹.) 553.8 491
Reserves (₹ Cr.) 7,891 6,987
P/BV 12.68 14.30
PE 96.31 97.33
From the Market
52 Week Low / High (₹) 4789.20 / 7319.95
All Time Low / High (₹) 5.62 / 7319.95
Market Cap (₹ Cr.) 1,00,947
Equity (₹ Cr.) 71.9
Face Value (₹) 5
Industry PE 41.2

Management X-Ray of Apollo Hospital Ent.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *16.3716.3716.3716.6316.3016.0916.0916.0916.0913.99
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Apollo Hospital Ent.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales4,5935,5886,3017,1838,3379,7944,6546,0986,5257,274
Operating Expenses 3,9154,8525,5496,3557,3208,3863,9454,6794,8435,476
Manufacturing Costs3415886237257729038149791,0301,216
Material Costs2,4242,8653,3643,8014,3695,1821,2231,9291,8611,999
Employee Cost 7218369421,1191,2951,5191,2181,1511,2721,425
Other Costs 429563620710884782691620680837
Operating Profit 6787377528281,0171,4097091,4191,6821,798
Operating Profit Margin (%) 14.8%13.2%11.9%11.5%12.2%14.4%15.2%23.3%25.8%24.7%
Other Income 4540481414182147152180
Interest 83134200240268426340244239250
Depreciation 158201241272300482421363367399
Exceptional Items -15-26000164-9-700
Profit Before Tax 467417359330463682-408521,2281,329
Tax 121837497160212-14280143318
Profit After Tax 347334285233303470-265731,0851,011
PAT Margin (%) 7.5%6.0%4.5%3.2%3.6%4.8%-0.6%9.4%16.6%13.9%
Adjusted EPS (₹)24.924.020.516.821.833.8-1.839.875.470.3
Dividend Payout Ratio (%)23%25%29%30%28%18%-163%30%20%23%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 3,1613,3163,5793,6933,8843,9885,2026,1116,9257,711
Share Capital 70707070707072727272
Reserves 3,0923,2463,5093,6243,8143,9195,1306,0396,8537,639
Minority Interest0000000000
Debt1,5172,1562,6692,8973,0532,9572,2812,0241,6251,786
Long Term Debt1,4612,0032,6202,5472,5972,5001,9651,9081,5201,786
Short Term Debt56153493504564573161161050
Trade Payables320401392473536727850653633758
Others Liabilities 8229651,2481,5171,8053,4402,4212,8233,0993,975
Total Liabilities 5,8206,8387,8888,5819,27811,11210,75311,61112,28214,229

Fixed Assets

Gross Block3,2023,4564,2474,6735,1758,1467,0257,3887,6398,936
Accumulated Depreciation7743956479121,2052,0901,9872,2672,5612,904
Net Fixed Assets2,4283,0613,6003,7623,9706,0565,0385,1215,0786,032
CWIP 5125363286988192272192496200
Investments 7138771,0649001,0851,0762,0912,0592,2172,621
Inventories33338144353956170721014798119
Trade Receivables5505466647509099661,204824820808
Cash Equivalents 249256273295278347408557318342
Others Assets1,0361,1801,5171,6381,6561,7331,5832,8793,6544,107
Total Assets 5,8206,8387,8888,5819,27811,11210,75311,61112,28214,229

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 3896266325399071,0969151,2011,2251,191
PBT 4674173593304636821779951,2281,329
Adjustment 240339438555615796887654493506
Changes in Working Capital -2236-71-228-14-131-152-350-173-313
Tax Paid -94-133-95-118-157-2514-99-323-330
Cash Flow From Investing Activity -681-910-804-378-776-264-765-505-589-835
Capex -685-773-576-518-583-437-194-519-394-620
Net Investments 9-161-238102-196167-5914-33-328
Others -524113846209-162113
Cash Flow From Financing Activity 332290130-106-160-771-176-577-779-297
Net Proceeds from Shares 0000001,152000
Net Proceeds from Borrowing 54171800000000
Interest Paid -83-134-279-257-311-460-269-187-175-176
Dividend Paid -80-1620-100-84-155-38-43-255-216
Others -46-133408252235-156-1,020-347-34995
Net Cash Flow 407-4354-2862-25119-14359
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)11.3210.318.276.417.9911.95-0.5710.1216.6413.81
ROCE (%)12.3910.499.328.7610.5815.534.114.0417.4317.2
Asset Turnover Ratio0.860.880.860.870.930.960.430.550.550.55
PAT to CFO Conversion(x)1.121.872.222.312.992.33N/A2.11.131.18
Working Capital Days
Receivable Days40363536363585614641
Inventory Days242324252424361175
Payable Days434643424245235142126127

Apollo Hospitals Enterprise Ltd Stock News

Apollo Hospitals Enterprise Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Apollo Hospital Ent. on 31-Oct-2024 16:01 is ₹7,000.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Oct-2024 16:01 the market cap of Apollo Hospital Ent. stood at ₹1,00,946.9.
The latest P/E ratio of Apollo Hospital Ent. as of 31-Oct-2024 16:01 is 96.31.
The latest P/B ratio of Apollo Hospital Ent. as of 31-Oct-2024 16:01 is 12.68.
The 52-week high of Apollo Hospital Ent. is ₹7,320 and the 52-week low is ₹4,789.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Apollo Hospital Ent. is ₹7,522 ( Cr.) .

About Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise was established in 1983, renowned as the architect of modern healthcare in India. As the nation’s first corporate hospital, it is acclaimed for pioneering the private healthcare revolution in the country. The cornerstones of Apollo’s legacy are its unstinting focus on clinical excellence, affordable costs, modern technology and forward-looking research & academics. It was among the first few hospitals in the world to leverage technology to facilitate seamless healthcare delivery. The organization embraced the rapid advancement in medical equipments across the world, and pioneered the introduction of several cutting edge innovations in India.  Apollo Hospitals has championed numerous social initiatives - to cite a few which assist underprivileged children - SACHi (Save a Child's Heart Initiative) which screens and provides paediatric cardiac care for congenital heart diseases, SAHI (Society to Aid the Hearing Impaired) and the CURE Foundation focused on cancer care.

Business area of the company

The company has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several retail health models. The Group also has Telemedicine facilities across several countries, Health Insurance Services, Global Projects Consultancy, Medical Colleges, Medvarsity for E-Learning, Colleges of Nursing and Hospital Management and a Research Foundation. In addition, ‘ASK Apollo’ - an online consultation portal and Apollo Home Health provide the care continuum.

Services offered by the company:

  • Cardiology & Cardiothoracic Surgery
  • Orthopedics & Joint Replacement Surgery
  • Spine Surgery
  • Oncology
  • Medical & Surgical Gastroenterology
  • Neurology & Neurosurgery
  • Nephrology & Urology
  • Critical Care Medicine

Medical Milestones:

  • Touched over 42 Million lives and still counting.
  • Performed over 20 Million Preventive Health Checks so far.
  • 1 Million minor surgical procedures performed.
  • 7,50,000 major surgeries performed and counting.
  • Crossed over 1,50,000 Heart Surgeries with incredible success rates.
  • 1,25,000 Coronary Angioplasties done till 2013.
  • Completed over 10,000 Joint Replacement Surgeries.
  • 10,000 Neurosurgeries performed per year.
  • First program to complete over 15000 Kidney transplants.
  • Apollo Speciality Cancer Hospital, Chennai successfully completes 1500 CyberKnife Radio Surgeries.
  • Over 1500 solid organ transplants were performed in a year.
  • Apollo Speciality Cancer Hospital, Chennai successfully completes 1500 CyberKnife Radio Surgeries.
  • 1000 patients successfully treated through exultant Micro vascular free tissue transfer and Aesthetic surgeries.
  • First program to complete over 3500 Liver transplants.
  • Over 1500 Bone Marrow Transplants.
  • Apollo Health City has performed 1500 Cochlear implant surgery and reached a new milestone in the history of aiding hearing impaired in Andhra Pradesh.
  • 375 liver transplants performed by Apollo Hospitals, Chennai and Delhi.
  • 345 liver transplantations at Apollo Chennai's Center for Liver Disease.
  • Countries Medical Value Travel.
  • 25 World Class Heart Institutes.
  • 25 NABH (National Accreditation Board for Hospitals) accredited hospitals.
  • 8 JCIA accredited hospitals.
  • 6 centres in India on global trial for drug-eluting bio-resorb able stents. Apollo is one of them.

Achievements/Milestones

  • Apollo Hospitals, Chennai successfully performs Asia's first en-bloc combined heart & liver transplant, joining a very small set of transplant centers in the world to have done this.
  • Apollo Hospitals, Hyderabad successfully treats a critically ill eleven day old baby with a complex and rare cardiac surgery - a first of its kind in India.
  • Apollo Hospitals, Chennai introduces 'the Ideal Knee' - the future of Total Knee Replacement through a new technique - Attune Rotating Platform Knee Replacement, a first of its kind in South India.
  • Apollo Health City, Hyderabad performed the First bilateral (on both the knees) revolutionary Minimally Invasive Knee Replacement (Resurface) Surgery (MIKRS) using OrthoGlide Medial Knee system.
  • Apollo Hospitals, Chennai successfully performed a Robotic surgery for Cancer base of the tongue, a first of its kind in Tamil Nadu.
  • Thoraco Omphalopagus conjoined female twins from Tanzania were successfully separated at Apollo Children's Hospital.
  • Pioneered open heart surgeries and cardiac catheterization, in the early 80's.
  • First private healthcare provider to perform a heart transplant in 1995.
  • By 1992, Apollo Hospitals introduced Artery Stenting for the first time in India.
  • Indraprastha Apollo Hospitals, Delhi completed over 500 liver transplants in February, 2011.
  • In 1995, Apollo Hospitals performed its first Bone Marrow Transplantation, as well as the first multi organ transplant in the country.
  • Pediatric Surgeons at Apollo Children's Hospital Chennai evolved their own standardized techniques for valve repair, April to June 2012.
  • Apollo Hospitals, Hyderabad performed the first coronary angioplasty in India using absorb fully absorbable stent-bioresorbable vascular scaffold (absorb-BVS) - 2012.
  • Apollo Health City Hyderabad commenced Robotic Procedures during April to June 2012, in the specialities of Gynecology & Urology.
  • Indraprastha Apollo Hospitals New Delhi commenced Robotic Surgery in the specialities of Gynecology, Urology, General Surgery and Bariatric Surgery, during April to June 2012.
  • Apollo Gleneagles Cancer Hospital launched Eastern India's first dedicated comprehensive Bone Marrow Transplant Unit.
  • Apollo Hospitals, Chennai performed a double-lung transplantation for Hermansky-Pudlak Syndrome (HPS) genetic condition which was the first case in India and second in the world. HPS results from mutations in one of seven different genes.
  • Apollo performed an unprecedented revolution in orthopedics by equalizing limbs and deformity correction by the llizarov procedure.
  • An 8 year old Omani child with aortoarteritis, uncontrollable hypertension with impending kidney failure and intestinal gangrene was successfully treated by vascular reconstructive surgery at Apollo hospitals Chennai.
  • World's 1st iPod Navigation Hip Resurfacing Surgery was successfully performed at Apollo Speciality Hospitals, Chennai.
  • Latest M guard stent technology, a specially designed Mesh covered stent, was used to save a 27 year old man from an acute heart attack, Apollo Hospital first to introduce the technology in Chennai.
  • First American underwent a successful Heart Transplant at Chennai's Apollo Hospitals and he was also the oldest person to undergo a heart transplant in the country.
  • Apollo Bramwell Hospital Mauritius in conjunction with Global Biohealth Solutions, launched the Apollo Bramwell Stem Cell Therapy Program.
  • Introduced cutting edge procedures like off-pump and beating-heart surgery, either by thoracotomy or classical sternotomy, trans-radial angioplasty and stenting, mitral valve replacement.
  • First donor incompatible kidney transplant performed at Apollo Hospitals Chennai using technique of Column adsorption of blood group antibodies.
  • Stealth Surgery, a subcutaneous endoscopic surgery which addresses concerns related to scarring was performed at Apollo Children's Hospital, Chennai.
  • Largest series of aortic valve replacement with stentless heart valve bioprosthesis performed.
  • Apollo Hospitals, Chennai successfully performed the first simultaneous Liver-Intestine-Pancreas transplant in India.
  • Apollo Hospitals, Chennai successfully performed a combined heart and lung transplant on the oldest recorded recipient in India.
  • Apollo Hospitals, Chennai completes the highest number of Combined Heart and Double Lung Transplants in India.
  • India's first Total Marrow Irradiation Procedure was performed on a 35-year-old patient from Oman by Apollo Proton Cancer Centre, Chennai.
  • India's first successful combined cardiac and tracheal surgery was performed on 11-month-old baby from Oman by Apollo Children's Hospital, Chennai.
  • Asia's first simultaneous Kidney-Pancreas Transplant was performed on a 38-year-old patient by Apollo Hospitals, Chennai.
  • Apollo Hospitals, Chennai successfully performed over 50,000 cardiac surgeries which includes Bypass, Valve replacements, Pediatric cardiac procedures, Transplants and Minimally invasive procedures.
  • The first ever Transfemoral Pulmonary Valve Implantation using an Indian-made valve, MYVAL, was performed by Apollo Hospitals, Chennai.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.